- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
NEW YORK ( TheStreet) -- Jazz Pharmaceuticals (Nasdaq: JAZZ) hit a new 52-week high Friday as it is currently trading at $72.39, above its previous 52-week high of $72.24 with 291,091 shares traded as of 11:50 a.m. ET. Average volume has been 968,800 shares over the past 30 days. Jazz has a market cap of $4.09 billion and is part of the health care sector and drugs industry. Shares are up 30.9% year to date as of the close of trading on Wednesday. Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other countries.